“If you have ovarian cancer, ask your oncologist to consider a test that will help determine whether your cancer is one of just under 50 per cent that might be responsive to new treatment options such as PARP inhibitors," says cancer researcher Professor Anna deFazio.
If you have ovarian cancer, genomic testing may open up new treatment option
December 18, 2024 BioPharmaAustralian BiotechLatest Video
New Stories
-
Make the institution and its nobility work for patients, not the other way around
January 16, 2025 - - Latest News -
Could this system's 'nobility' embrace a new idea, even if they recognised it?
January 15, 2025 - - Latest News -
Patients do not live their condition as aggregated economic models
January 14, 2025 - - Latest News -
Delays were the intended outcome, not an unintended consequence
January 13, 2025 - - Latest News -
Attitudes may have evolved, but the framework they created remains virtually unchanged
January 13, 2025 - - Latest News -
Boehringer Ingelheim's Auckland office leads sustainability in NZ pharma sector
January 10, 2025 - - Latest News -
Companies welcome November PBAC outcomes
December 23, 2024 - - Latest News